SCHEMBL24577253

SCHEMBL24577253

Cc1cc(C(=O)NCCN2CCCCC2)sc1NC(=O)c1cnn2cc(-c3cnn(C)c3)sc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 1/20 0.39
▸ KIT P10721 1/20 0.39
▸ STAT3 P40763 3/20 0.39
▸ CHRM1 P11229 1/20 0.37
▸ PDGFRA P16234 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ RAD52 P43351 2/20 0.36
▸ HTR4 Q13639 1/20 0.36
▸ SRC P12931 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ STAT1 P42224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24577246 0.99 KIT (0.40) ACKR3KITSTAT3CHRM1PDGFRA
SCHEMBL24577851 0.92 CHRM1 (0.38) ACKR3KITSTAT3CHRM1PDGFRA
SCHEMBL24578906 0.91 CHRM1 (0.39) ACKR3KITSTAT3CHRM1PDGFRA
SCHEMBL24577250 0.91 NTRK1 (0.37) KITSTAT3CHRM1PDGFRAHRH3
SCHEMBL24577196 0.90 CHRM1 (0.36) KITSTAT3CHRM1PDGFRAHRH3
SCHEMBL24577938 0.90 CHRM1 (0.34) KITSTAT3CHRM1PDGFRAHRH3
SCHEMBL24578970 0.89 CHRM1 (0.38) KITSTAT3CHRM1PDGFRAHRH3
SCHEMBL24577940 0.88 CHRM1 (0.35) CHRM1PDGFRAHRH3MARK3JAK2
SCHEMBL24578949 0.88 CHRM1 (0.35) CHRM1PDGFRAHRH3MARK3JAK2
SCHEMBL24577243 0.88 CHRM1 (0.35) CHRM1PDGFRAHRH3MARK3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback